These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists. Green AR; Hall JE; Rees AR Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345 [TBL] [Abstract][Full Text] [Related]
29. Environmental influences upon drug-induced suppression of operant behavior. Sparber SB; Tilson HA J Pharmacol Exp Ther; 1971 Oct; 179(1):1-9. PubMed ID: 5096565 [No Abstract] [Full Text] [Related]
30. Modification of apomorphine hypothermia by drugs affecting brain 5-hydroxytryptamine function. Menon MK; Vivonia CA Eur J Pharmacol; 1981 Dec; 76(2-3):223-7. PubMed ID: 7333357 [TBL] [Abstract][Full Text] [Related]
31. [Excellence of quipazine in the characterization of serotoninergic receptors and mechanisms]. Hong E Gac Med Mex; 1982 Apr; 118(4):158-64. PubMed ID: 7117731 [No Abstract] [Full Text] [Related]
32. The quipazine- and TFMPP-increased conditioned avoidance response in rats: role of 5HT1C/5-HT2 receptors. Alhaider AA; Ageel AM; Ginawi OT Neuropharmacology; 1993 Dec; 32(12):1427-32. PubMed ID: 8152532 [TBL] [Abstract][Full Text] [Related]
33. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation. Eison AS; Eison MS; Yocca FD; Gianutsos G Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627 [TBL] [Abstract][Full Text] [Related]
34. Neuronal 5-hydroxytryptamine receptors outside the central nervous system. Wallis D Life Sci; 1981 Dec; 29(23):2345-55. PubMed ID: 7033702 [No Abstract] [Full Text] [Related]
35. Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan. Yamamoto T; Walker EA; Woods JH J Pharmacol Exp Ther; 1991 Sep; 258(3):999-1007. PubMed ID: 1890629 [TBL] [Abstract][Full Text] [Related]
36. Quipazine induced wet dog shake behaviour in rats: mechanism of action. Hiremagalur ; Keshavan JH; Dandiya PC; Gurbani NK Pharmacol Res Commun; 1980 Sep; 12(8):757-68. PubMed ID: 6160597 [No Abstract] [Full Text] [Related]
37. The effect of quipazine, a serotonin receptor agonist, on serum corticosterone concentration in rats. Fuller RW; Snoddy HD; Clemens JA Endocr Res Commun; 1978; 5(2):161-71. PubMed ID: 309816 [TBL] [Abstract][Full Text] [Related]
39. Yohimbine-induced stimulus control in the rat. Winter JC Arch Int Pharmacodyn Ther; 1978 Sep; 235(1):86-92. PubMed ID: 736694 [TBL] [Abstract][Full Text] [Related]
40. Sensitivity to psychoactive drugs and the serotonergic neuronal system. Appel JB; Joseph JA; Utsey E; Hernandey LL Commun Psychopharmacol; 1977; 1(6):541-51. PubMed ID: 147154 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]